fbpx Yourgene Health plc - Home
Infectious Disease
Clarigene RUO
Clarigene CE-IVD
Clarigene SARS-CoV-2 CE-IVD
Clarigene™ Feature Notes
NIPT
IONA® Nx
For Clinical Laboratories
Overview
Workflow
Clinical Performance
Benefits of the IONA® Nx NIPT Workflow
Instruments
IONA® Software
Atlas Workflow Manager
MyNIPT®
Technical Support
Quality and Regulatory
Choose IONA® Nx NIPT Workflow
the IONA® test
For Clinical Laboratories
Overview
Technology
CE-IVD
Clinical Performance
Results
MyNIPT®
Application Support
FAQs
Choose IONA®
Laboratory Customer Login
For Pregnant Women
For Healthcare Professionals
Overview
Background
Clinical Performance
Results
MyNIPT®
Who can have the IONA® Test
FAQs
Responsible Screening
Choose IONA®
Resources
Contact Us
Sage™ Prenatal Screen
For Clinical Laboratories
Overview
Technology
Clinical Performance
Results
Choose Sage™
Sage QS 32plex
For Pregnant Women
Advantages of the Sage™ prenatal screen
Overview
Who can have the Sage™ test
Results
For Healthcare Professionals
Overview
Background
Who can have the Sage™ test
Clinical Performance
Results
Clinical Performance
Results
Contact Us
Reproductive Health
Cystic Fibrosis
Cystic Fibrosis Analysis
Choose CF-EU2
Male Infertility
Pregnancy Loss
Rapid Aneuploidy Analysis
QST*R Range
QST*R Feature Notes
Thrombosis Risk Panel
Precision Medicine
Elucigene DPYD
DPYD Overview
DPYD Testing Workflow
Clinical Performance
Choose Elucigene DPYD
Yourgene Flex™
DNA Size Selection / Enrichment
Ranger Technology
LightBench®
Overview
Get to the DNA you care about in NIPT
Get to the DNA you care about in Liquid Biopsy
NGS QC
LightBench® Feature Notes
Yourgene® QS250
Yourgene® SP150

Industry-Leading Repeatability

The proprietary method for electrophoretic mobility assessment used by Ranger® Technology enables it to control that mobility through real-time voltage manipulation. This control is exercised continuously until the target DNA fraction has arrived at a point in the gel cassette from which it can be extracted. When that is achieved, Ranger® Technology initiates the extraction process, ensuring the precise target DNA fragment lengths are recovered over multiple samples..

Fragment Analyzer (Advanced Analytical Technologies) Image
Fragment Analyzer (Advanced Analytical Technologies) evaluation of small RNA libraries that have gone through size selection with Ranger Technology. A target range of 130bp to 150bp was set for each sample, and each sample was processed repeatably despite differences between the samples that led to varied electrophoretic mobilities. (Image courtesy of Dr. J. Russ Carmical, Center for Metagenomics & Microbiome Research, Baylor College of Medicine).

Accurate Fragment Length Estimation

Throughout the electrophoretic documentation process, Ranger® Technology captures images to record the mobility of DNA in the sample. During each imaging sequence photos are taken with a blue excitation lights, and then another with red excitation lights. The blue images reveal the location of all DNA in the sample. The red images reveal only the location of internal reference markers, which are exclusively labelled with a secondary fluorophore.

This two-colour system allows Ranger® Technology to leverage reference markers that are close in size to the desired DNA size range of interest. The internal reference markers are always identified by Ranger® Technology’s machine vision suite, regardless of overlap with DNA fragments of similar length. Coastal Genomics supports a variety of different internal reference marker sizes that users can select from to optimize the performance of the platform for specific assays.

Assessment of GeneRuler 100 bp Plus dsDNA ladder (Thermo Fisher) Image
Assessment of GeneRuler 100 bp Plus dsDNA ladder (Thermo Fisher). Electrophoretic traces, as well as human- and machine-readable reports, are generated by Ranger® Technology.

High Recovery Yields

Ranger® Technology combines accurate fragment length estimation and controlled migration of DNA to ensure that the recovery operation is conducted over the entire span of the target fragment lengths. Our internal testing reveals that recovery yields are consistently over 70%. Extraction volumes can be kept to under 35 ul volumes to ensure high concentration of DNA for downstream processing.

Ranger<sup>®</sup> Technology recovered all fragments between 70bp and 190 bp from a 20 bp dsDNA ladder (Lonza) Image
Ranger® Technology recovered all fragments between 70bp and 190 bp from a 20 bp dsDNA ladder (Lonza). Comparison of the electrophoretic traces of the input and size selected fraction indicate an average recovery yield of 73% across all targeted fragment sizes. Further tests involving solution-based fluorometric assays confirm recovery yields to be in excess of 70% (data not shown).